Cost sharing for breast cancer hormone therapy: How do dual eligible patients' copayment impact adherence.

MLA

Ma, Siyu, et al. “Cost Sharing for Breast Cancer Hormone Therapy: How Do Dual Eligible Patients’ Copayment Impact Adherence.” PLoS ONE, vol. 16, no. 5, May 2021, pp. 1–15. EBSCOhost, https://doi.org/10.1371/journal.pone.0250967.

APA

Ma, S., Shepard, D. S., Ritter, G. A., Martell, R. E., & Thomas, C. P. (2021). Cost sharing for breast cancer hormone therapy: How do dual eligible patients’ copayment impact adherence. PLoS ONE, 16(5), 1–15. https://doi.org/10.1371/journal.pone.0250967

Chicago

Ma, Siyu, Donald S. Shepard, Grant A. Ritter, Robert E. Martell, and Cindy Parks Thomas. 2021. “Cost Sharing for Breast Cancer Hormone Therapy: How Do Dual Eligible Patients’ Copayment Impact Adherence.” PLoS ONE 16 (5): 1–15. doi:10.1371/journal.pone.0250967.